#LINOCLN #NSE - PENNANT BREAKOUT

LINCOLN PHARMA
Breakout from a BULLISH PENNANT.
Positive Earnings Results.

Lincoln Pharma.
M.Cap ₹ 1,154 Cr PE 14.3
Item YOY Sep 2023
Sales ⇡ 11% 156
EBIDT ⇡ 8% 31.2
Net profit ⇡ 17% 27.6
EPS ⇡ 17% ₹ 13.80

Disclaimer:
For educational purpose only.
Please do your own research before taking any trades.

Happy Trading!

Komentarz:

LINCOLN PHARMA crossed 595.